Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells

被引：0
|
作者：
Xiaomin Feng
Hao Liu
Zhijie Zhang
Yixue Gu
Huisi Qiu
Zhimin He
机构：
[1] Cancer Hospital and Cancer Research Institute,
[2] Guangzhou Medical University,undefined
[3] Guangzhou,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 36卷
关键词：
Annexin A2; Cisplatin resistance; Apoptosis; p53; JNK; C-Jun; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines
    Duarte, Mariana Lemos
    de Moraes, Emanuela
    Pontes, Elizangela
    Schluckebier, Luciene
    de Moraes, Joyce Luana
    Hainaut, Pierre
    Ferreira, Carlos Gil
    CANCER LETTERS, 2009, 279 (01) : 57 - 64
  • [22] Inflammatory meditated mechanisms of cisplatin resistance in non-small cell lung cancer
    O'Byrne, K.
    Ryan, S-L.
    Heavey, S.
    Umezawa, K.
    Barr, M. P.
    Gray, S. G.
    Davies, A.
    Richard, D.
    Gately, K.
    Baird, A-M.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S84 - S84
  • [23] Long non-coding RNA AK001796 contributes to cisplatin resistance of non-small cell lung cancer
    Liu, Bin
    Pan, Chun-Feng
    Ma, Teng
    Wang, Jun
    Yao, Guo-Liang
    Wei, Ke
    Chen, Yi-Jiang
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 4107 - 4112
  • [24] IncreasedABCC2expression predicts cisplatin resistance in non-small cell lung cancer
    Chen, Yun
    Zhou, Hongying
    Yang, Sifu
    Su, Dan
    CELL BIOCHEMISTRY AND FUNCTION, 2021, 39 (02) : 277 - 286
  • [25] Increasing P53 Protein Sensitizes Non-Small Cell Lung Cancer to Paclitaxel and Cisplatin In Vitro
    Guntur, Vamsi P.
    Waldrep, J. Clifford
    Guo, Jennifer J.
    Selting, Kim
    Dhand, Rajiv
    ANTICANCER RESEARCH, 2010, 30 (09) : 3557 - 3564
  • [26] Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin
    Hu, Wenxia
    Jin, Pule
    Liu, Wei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (03) : 1199 - 1208
  • [27] Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
    Jie Xu
    Cai-feng Yue
    Wei-hua Zhou
    Yuan-min Qian
    Yan Zhang
    Shao-wu Wang
    An-wen Liu
    Quentin Liu
    Journal of Translational Medicine, 12
  • [28] Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer
    Ma, Ying
    Feng, Qin
    Han, Bateer
    Yu, Rong
    Jin, Zhiyong
    HEREDITAS, 2023, 160 (01)
  • [29] Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer
    Ying Ma
    Qin Feng
    Bateer Han
    Rong Yu
    Zhiyong Jin
    Hereditas, 160
  • [30] Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
    Xu, Jie
    Yue, Cai-feng
    Zhou, Wei-hua
    Qian, Yuan-min
    Zhang, Yan
    Wang, Shao-wu
    Liu, An-wen
    Liu, Quentin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
12345